Epstein Secrets

ree in 10 parents said they planned to vaccinate their children as soon as they could." In addition, "The survey found that public confidence in the Johnson & Johnson vaccine has plummeted since health authorities suspended using it for 10 days to examine possible links to a rare, dangerous blood dotting problem.

with over 600 deaths on Thursday. However, "a dramatically slowing rate of deaths and COVID infections tells us the vaccinations are working." NBC's Miguel Almaguer added, "Across the country, more than 40% of all adults are fully vaccinated. A new study finds when half the US is inoculated, the nation could pr

ication, 8.41M) also have reports. J&J Says It Should Have Enough Doses For More Than 20M By End Of March. The Hill (2/22, Sullivan, 5.69M) reports Johnson & Johnson said Monday that it "plans to have enough doses of its vaccine for more than 20 million Americans by the end of March" if its vaccine is authorized

the equivalent of nearly the entire city of Atlanta gone - more lives lost than those who live in Kansas City or Oakland or Miami or Minneapolis." Miguel Almaguer said on NBC Nightly NewsVi (2/22, lead story, 2:35, Holt, 6.18M), "The President, with the enormity of the death toll on his shoulders, paused to re

uccia, Subscription Publication, 8.41M), Politico (1/26, Cancryn, Roubein, 6.73M), and The Hill (1/26, Sullivan, Samuels, 5.69M) also have reports. Johnson & Johnson Expects To Report Vaccine Data Next Week. Reuters (1/26, Mishra, O'Donnell) reports that on Tuesday, Johnson & Johnson "said it expected to report

sk Of Spread. NBC Nightly NewsVi (1/26, story 2, 1:55, Holt, 6.26M) reported on the risk from "new and more contagious strains of the virus." NBC's Miguel Almaguer added, "Roughly half the country, including states like New York, Illinois, and California, have already confirmed cases of the highly contagious an

rapid cure for a pathogen like covid-19 for years." Johnson & Johnson Starts Human Vaccine Trials. The New York Post (7/30, O'Neill, 4.57M) reports Johnson & Johnson began human trials of its experimental COVID-19 vaccine on Thursday, "after the shots already proved successful in protecting monkeys, the drugmake

death toll from COVID-19 rises in this country, there's new concerns tonight about children with the disease and their ability to spread it." NBC's Miguel Almaguer added, "With the nation fast approaching 4.5 million cases, tonight a new study finds children under five may be able to spread COVID as well as ol

ine Use. The Washington Post (4/22, Al, McGinley, Sun, 10.52M) reports, "Federal health authorities are leaning toward recommending that use of the Johnson & Johnson coronavirus vaccine resume, possibly as soon as this weekend - a move that would include a new warning about a rare complication involving blood cl

t other half of the equation: reward." CDC Faces Pressure Over Outdoor Mask Guidance. On NBC Nightly NewsVi (4/22, lead story, 2:55, Holt, 4.83M), Miguel Almaguer reported that "the CDC faces growing pressure and questions over its long-standing guidance on face masks outdoors," as 24 states have repealed "th

rapid cure for a pathogen like covid-19 for years." Johnson & Johnson Starts Human Vaccine Trials. The New York Post (7/30, O'Neill, 4.57M) reports Johnson & Johnson began human trials of its experimental COVID-19 vaccine on Thursday, "after the shots already proved successful in protecting monkeys, the drugmake

death toll from COVID-19 rises in this country, there's new concerns tonight about children with the disease and their ability to spread it." NBC's Miguel Almaguer added, "With the nation fast approaching 4.5 million cases, tonight a new study finds children under five may be able to spread COVID as well as ol